Medrad and B Braun Melsungen Sign Licensing Agreement

Medrad has entered into a co-marketing and trademark license agreement with B Braun Melsungen to promote the Paccocath technology, a clinically tested technology used to treat blocked vessels without stenting.
TradingMarkets